Development
Cardinal Health, Inc.
CAH
$165.12
-$0.285-0.17%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 216.15B | 210.17B | 205.01B | 198.66B | 193.01B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 216.15B | 210.17B | 205.01B | 198.66B | 193.01B |
| Cost of Revenue | 208.92B | 203.13B | 198.12B | 192.00B | 186.45B |
| Gross Profit | 7.23B | 7.04B | 6.89B | 6.67B | 6.56B |
| SG&A Expenses | 4.93B | 4.83B | 4.83B | 4.72B | 4.68B |
| Depreciation & Amortization | 270.00M | 278.00M | 285.00M | 303.00M | 308.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 214.12B | 208.24B | 203.24B | 197.02B | 191.44B |
| Operating Income | 2.03B | 1.93B | 1.77B | 1.64B | 1.58B |
| Income Before Tax | 1.13B | 502.00M | 638.00M | 489.00M | -192.00M |
| Income Tax Expenses | 488.00M | 345.00M | 376.00M | 24.00M | 1.08B |
| Earnings from Continuing Operations | 641.00 | 157.00 | 262.00 | 465.00 | -1.27K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.00M | -1.00M | -1.00M | -2.00M | -1.00M |
| Net Income | 639.00M | 156.00M | 261.00M | 463.00M | -1.27B |
| EBIT | 2.03B | 1.93B | 1.77B | 1.64B | 1.58B |
| EBITDA | 2.73B | 2.62B | 2.46B | 2.34B | 2.28B |
| EPS Basic | 2.56 | 0.62 | 1.00 | 1.76 | -4.64 |
| Normalized Basic EPS | 4.93 | 4.56 | 4.05 | 3.56 | 3.30 |
| EPS Diluted | 2.54 | 0.61 | 0.99 | 1.74 | -4.65 |
| Normalized Diluted EPS | 4.91 | 4.54 | 4.03 | 3.54 | 3.29 |
| Average Basic Shares Outstanding | 1.00B | 1.02B | 1.04B | 1.06B | 1.08B |
| Average Diluted Shares Outstanding | 1.01B | 1.02B | 1.05B | 1.07B | 1.08B |
| Dividend Per Share | 2.00 | 1.99 | 1.99 | 1.97 | 1.97 |
| Payout Ratio | 79.66% | 329.49% | 201.15% | 115.12% | -42.50% |